Home › Biblio

Biblio

Found 9 results

2011
Kasamon YL, Jones RJ, Gocke CD, Blackford AL, Seifter EJ, Davis-Sproul JM, Gore SD, Ambinder RF.  2011.  Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):365-73. Abstract
2010
Smith DB, Kasamon YL, Kowalski J, Gocke C, Murphy K, Miller CB, Garrett-Mayer E, Tsai H-L, Qin L, Chia C et al..  2010.  K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(1):338-47. Abstract
Kasamon YL, Luznik L, Leffell MS, Kowalski J, Tsai H-L, Bolaños-Meade J, Morris LE, Crilley PA, O'Donnell PV, Rossiter N et al..  2010.  Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(4):482-9. Abstract
2009
Jones RJ, Gocke CD, Kasamon YL, Miller CB, Perkins B, Barber JP, Vala MS, Gerber JM, Gellert LL, Siedner M et al..  2009.  Circulating clonotypic B cells in classic Hodgkin lymphoma.. Blood. 113(23):5920-6. Abstract
Kasamon YL, Wahl RL, Ziessman HA, Blackford AL, Goodman SN, Fidyk CA, Rogers KM, Bolaños-Meade J, Borowitz MJ, Ambinder RF et al..  2009.  Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(2):242-8. Abstract
2007
Bolaños-Meade J, Garrett-Mayer E, Luznik L, Anders V, Webb J, Fuchs EJ, Huff CA, Matsui W, Borrello IM, Brodsky R et al..  2007.  Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(10):1185-91. Abstract
Kasamon YL, Jones RJ, Wahl RL.  2007.  Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 48 Suppl 1:19S-27S. Abstract
2005
Kasamon YL, Jones RJ, Diehl LF, Nayer H, Borowitz MJ, Garrett-Mayer E, Ambinder RF, Abrams RA, Zhang Z, Flinn IW.  2005.  Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 11(1):39-46. Abstract
Kasamon YL, Jones RJ, Piantadosi S, Ambinder RF, Abrams RA, Borowitz MJ, Morrison C, Smith DB, Flinn IW.  2005.  High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 11(2):93-100. Abstract

Your Support is the Key

Submitted by admin on May 9, 2011 - 11:20am

Matthew Slattery

Help children like Matthew unlock their potential by becoming a Partner in Potential.

Donate Learn More